Growth Retardation Clinical Trial
Official title:
Visual Interpretation of Neonatal Growth Charts: A Comparison of Z-score Charts and Traditional Charts
Verified date | June 2017 |
Source | University of California, Davis |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
Simulated growth data will be shown to clinicians in two formats - (1) as weight vs.age charts, (2) as weight Z-score vs. age charts. Clinicians will be asked to identify whether growth is too fast, too slow, or normal. The test will take a total of 10 minutes.
Status | Completed |
Enrollment | 50 |
Est. completion date | May 2016 |
Est. primary completion date | November 2015 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | N/A and older |
Eligibility |
Inclusion Criteria: It will include UC Davis Medical Center healthcare personnel who interpret growth charts for preterm infants. This may include the following: - Attending Neonatologists - Attending Pediatricians - Dietitians - Medical Students - Neonatal Fellows - Neonatal Nurse Practitioners - Pediatric Residents This study will exclude persons who do not routinely interpret growth charts for preterm infants as part of their clinical responsibilities. Exclusion Criteria: - None |
Country | Name | City | State |
---|---|---|---|
United States | UC Davis | Sacramento | California |
Lead Sponsor | Collaborator |
---|---|
University of California, Davis |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Correct answers | Baseline |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT02249754 -
Nutrition Education Package for Infants and Young Child Feeding and Health in Rural Tanzania
|
N/A | |
Completed |
NCT02438774 -
Intervention in Minimizing Aflatoxins and Fumonisins Exposure to Children Through Food and Breastfeeding in Tanzania
|
N/A | |
Recruiting |
NCT03053687 -
Effect of Nutritional Formula Supplementation on Growth Rate of Growth Hormone (GH) Treated Children With Growth Hormone Deficiency (GHD) After the Second Year of Therapy
|
N/A | |
Completed |
NCT03217045 -
Nutrition Protocol and Premature Infants' Growth
|
||
Recruiting |
NCT04294368 -
Targeted Fortification of Donor Breast Milk in Preterm Infants
|
N/A | |
Completed |
NCT02716935 -
Prebiotics and Microbiota Composition and Functionality in Rural Burkinabe Infants
|
N/A | |
Completed |
NCT02236468 -
Creating Homestead Agriculture for Nutrition and Gender Equity (CHANGE) in Burkina Faso
|
N/A | |
Not yet recruiting |
NCT01494779 -
Evaluation of Pharmacokinetic and Pharmacodynamic Parameters of Somatropin Produced by Laboratory Blausiegel Indústria e Comércio Ltda., Compared to Saizen® From Laboratory Merck Serono S.A.
|
Phase 1 | |
Completed |
NCT05946928 -
EMERGENCE AGITATION After Premedication IN PAEDIATRIC MAGNETIC RESONANCE IMAGING: A RETROSPECTIVE COHORT STUDY
|
||
Recruiting |
NCT03290235 -
Extension Study of Pegylated Somatropin to Treat Growth Retardation Caused by Endogenous Growth Hormone Deficiency in Children
|
Phase 4 | |
Completed |
NCT02259166 -
Enhanced Homestead Food Production Plus+ Program in the Lake Zone, Tanzania
|
N/A | |
Recruiting |
NCT06071403 -
The Effects of Time Points to Cease Parenteral Nutrition and IGF-1 on Very Low Birth Weight Infants
|
||
Completed |
NCT05640596 -
Antenatal Corticosteroid Therapy: Which Impact on Birth Parameters?
|
||
Completed |
NCT04633135 -
Research on Emissions, Air Quality, Climate and Cooking Technologies in Northern Ghana
|
N/A | |
Completed |
NCT00174278 -
Treatment With Recombinant Human Growth Hormone Genotonorm (Registered) In Children With Short Stature Secondary
|
Phase 3 | |
Recruiting |
NCT05518188 -
Melpida: Recombinant Adeno-associated Virus (Serotype 9) Encoding a Codon Optimized Human AP4M1 Transgene (hAP4M1opt)
|
Phase 1/Phase 2 | |
Completed |
NCT03635944 -
Nutritional Care and Head Growth in Preterm Infants
|
||
Completed |
NCT00813189 -
Efficacy Study of Recombinant Growth Hormone on Muscle Function in Children Long-term Treated With Glucocorticoid
|
Phase 3 |